More on PASG

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.0 Score)
- Holders

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Passage Bio (NQ:PASG)
Delayed: 4.83 -0.08 (1.63%)
Prev. Close $4.91  
Open$4.90 
52 Wk High$ 
52 Wk Low$ 
Day High$4.91 
Day Low$4.68 
P/E N/A  
EPS$ 
Volume55,431 


Jul 2, 2026 09:20 PM Form SCHEDULE 13D Passage BIO, Inc. Filed by: Lynx1 Capital Management LP
Jun 29, 2026 04:31 PM Form 4 Passage BIO, Inc. For: Jun 25 Filed by: Nichols Weston
Jun 25, 2026 06:45 PM Form SCHEDULE 13G Passage BIO, Inc. Filed by: Baselake Partners, LP
Jun 24, 2026 05:11 PM Form 425 Passage BIO, Inc. Filed by: Passage BIO, Inc.
Jun 24, 2026 04:17 PM Form 425 Passage BIO, Inc. Filed by: Passage BIO, Inc.
Jun 24, 2026 04:17 PM Form 8-K Passage BIO, Inc. For: Jun 23
Jun 24, 2026 04:06 PM Passage Bio and Remix Therapeutics agree to all-stock merger deal
Jun 24, 2026 04:05 PM Passage Bio and Remix Therapeutics Announce Merger Agreement
Jun 10, 2026 06:47 AM Guggenheim Downgrades Passage Bio Inc. (PASG) to Neutral
May 27, 2026 04:19 PM Passage Bio terminates collaboration deal, exits office lease
View All Articles

Entities mentioned with PASG

View All Entities